Please try another search
We issued an updated research report on The Timken Company (NYSE:TKR) on Sep 26. The company’s near-term results are likely to bear the brunt of input cost inflation due to the implementation...
Tesla (NASDAQ:TSLA) shares rallied strongly to the news that the company was within shouting distance of a 100,000 vehicle delivery milestone.The eccentric CEO Elon Musk who has been criticized by...
Consus Real Estate has further expanded its project portfolio with four acquisitions of development projects with c €1.2bn of gross development value (GDV) signed so far this year. As a result,...
Following its August trading update highlighting a slowdown in new sales, Brady’s interim results were in line with our expectations. H119 revenue was £9.5m, a 9% fall vs...
US consumer spending continued to grow in August, suggesting that the economy’s main growth driver is still fueling the longest economic growth period in history. Consumer spending, which...
Peloton (NASDAQ:PTON) made its market debut this week, opening on the NASDAQ at $27, which was below its IPO pricing of $29 per share. The firm’s shares closed down over 11% on its first day of...
Open Interest in options contracts can be an important indicator of how the price of a stock is likely to move, especially during the period when options are about to expire.Why? – Because of...
The Q3 reporting season will really get underway when the big banks report results in mid-October, but the earnings season has actually started already with results from 15 S&P 500 members out. We...
Another disappointing IPO hit the markets with Peloton (NASDAQ:PTON) shares spinning their wheels and going nowhere but down. PTON’s IPO’ed at $29 per share and broke down 11% to below $26...
MACROS&P 500 (SPY (NYSE:SPY)Regardless stocks didn’t have a great day falling by 24 bps. What is worse to some degree is that the index failed yet again at 2986. However, the good news is...
Here at Zacks, we try to avoid labeling stocks as “expensive” or “cheap.” Instead, we look far beyond face value, and our system puts an emphasis on earnings estimate revisions...
IPOs are failing. And that's not a good sign. Pulled IPOs are even worse than bad IPOs. Ringing the Bell I disagree with Peter Schiff about many things, but that's not one of them. Apologies for the...
U.S.-China trade tensions and geopolitical uncertainty has been a boon for gold prices in recent months, and mining shares have benefited from this increased appetite for the safe-haven asset. Two...
AbbVie Inc . (NYSE:ABBV), which I’ve been following for a long time, made a monster move going from the end of 2014 to 2017 to the 125-130 range. It spent about a year and a half coming down,...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 27th:Aclaris Therapeutics, Inc. (ACRS): This biopharmaceutical company has a Zacks...